Evidence mapPaperPMID 41969348Full record

ArticleFrontiers in psychiatry2026

Correlation between symptom distress and quality of life in patients with Chronic Kidney Disease Stage 5 undergoing hemodialysis in China: a multi-center cross-sectional study.

Xue Qiao, Yifei Wang, Zhaoyang Tian, Yongli Zhan, Tao Yang, Jie Luan, Erping Yan, Xiaojuan Li, Tang Tang, Qiang Ji and 26 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Brain structure & function · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Xue QiaoWangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yifei WangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zhaoyang TianDialysis Unit, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yongli ZhanDepartment of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Tao YangNephrology Rehabilitation Center, Beijing Zhongguancun Hospital, Beijing, China.
Jie LuanBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Erping YanBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xiaojuan LiBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Tang TangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Qiang JiBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Tianxu YangDialysis Unit, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.
Li WangDepartment of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Li WanNephrology Rehabilitation Center, Beijing Zhongguancun Hospital, Beijing, China.
Guangqin MuNephrology Rehabilitation Center, Beijing Zhongguancun Hospital, Beijing, China.
Yanhui LiBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Shaohua WangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Jin QianBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Lulu LiuBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Pingping SunBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Rui JingBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zhan WangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Fangfang KangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yu KangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Lu XuBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Jianying HaoBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yushan YangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yan RenBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xingxing PangBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Shuo BaiBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yaxin ZhuBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yina HeDepartment of Artificial Intelligence, Xiamen University, Xiamen, China.
Wen ZhangSchool of Public Health, Sun Yat-sen University, Guangzhou, China.
Tianxu ZhangWangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zhenze HanGraduate School, Beijing University of Chinese Medicine, Beijing, China.
Peng LiuBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Moyan QiuBlood Purification Center, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To explore the symptom distress and quality of life status of patients with Chronic Kidney Disease (CKD) Stage 5 undergoing hemodialysis in China, and their correlation. Methods: The Dialysis Symptom Index (DSI) and the Kidney Disease Quality of Life Short Form (KDQOL-SF™ 1.3), two widely used assessment tools for hemodialysis patients, were used for evaluation. Results: The patients reported an average of 13 symptoms. The most common symptoms were worrying (99.7%), sexual dysfunction (>90%), and trouble falling asleep (90.8%). The KDQOL-SF™ 1.3 showed that patients had lower scores in dimensions such as "Burden of Kidney Disease" and "Work Status," while they had higher scores in the "Dialysis Staff Encouragement" and "Role Limitations - Emotional" dimensions. Univariate analysis revealed that age, education level, employment status, dialysis frequency, dialysis modality, primary disease, multiple comorbidities, complications (renal anemia), and polypharmacy were significantly associated with the total DSI score. Spearman's rank correlation analysis showed a negative correlation between the total DSI score and each dimension of KDQOL-SF™ 1.3, with the strongest correlation found with the "Symptom/Problem List" dimension. Multivariate linear regression analysis indicated that age, education level, dialysis duration, dialysis modality, and primary disease (diabetic nephropathy) were independent influencing factors for the total DSI score. After controlling for confounding factors, the total DSI score remained independently negatively correlated with multiple dimensions of KDQOL-SF™ 1.3. Conclusions: Symptom distress is negatively correlated with quality of life in Chinese CKD Stage 5 hemodialysis patients. Clinical attention should be given to symptom screening and management.

Indexed as

Chronic Kidney Diseasecross-sectional studyhemodialysisquality of lifesymptom distress

Identifiers

PMID41969348
PMCPMC13066137

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.